Browse Drug delivery systems topic

Product development subtopic

Articles 1-38 out of 38 article(s) Title Author Type Date Words pSivida Announces Positive Results from the Two Phase 3 FAME[TM] Trials of Iluvien[R] in Patients with Diabetic Macular Edema. Dec 23, 2009 2365 pSivida Announces Last Patient in Phase III Iluvien[R] Trial Completes 2 Year Follow-Up Visit. Oct 14, 2009 804 Omnia Biologics and AparnaBio Sign Lentivirus Drug Development Agreement. Aug 18, 2009 232 A.P. Pharma Presents APF530 Phase 3 Data at Annual Meeting of the American Society of Clinical Oncology. Clinical report Jun 1, 2009 1018 APF530 Phase 3 Data for Chemotherapy-Induced Nausea and Vomiting to be Presented at American Society of Clinical Oncology 2009 Annual Meeting. May 18, 2009 690 pSivida Corp. Reports Iluvien[TM] Phase III Studies for DME Pass Final DSMB Review Prior to October Readout. Apr 8, 2009 940 Halozyme Begins Phase 1 Clinical Study with PEGPH20 in Cancer Patients with Refractory Solid Tumors. Mar 31, 2009 750 pSivida Corp: Enrollment complete in BrachySil[TM] Dose Ranging Study. Mar 4, 2009 783 CPEX Pharmaceuticals Announces Completion of Phase 2 Trial for Urology Drug by Serenity Pharmaceuticals. Feb 26, 2009 551 BioDelivery Sciences Announces Initial Results of Phase 1 Clinical Study of Bioral Amphotericin B. Feb 5, 2009 925 PII and NexMed Enter into Strategic Collaboration Agreement for NexMed's NexACT[R] Drug Delivery Platform. Jan 22, 2009 503 MacuCLEAR and Mystic Pharmaceuticals Agree To Collaborate on Macular Degeneration Phase I/II Clinical Trial. Jan 13, 2009 457 pSivida New Clinical Trial for Drug Delivery Device in AMD. Dec 11, 2008 816 CPEX Pharmaceuticals Announces Initiation of Phase II Trial for Urology Indication by Serenity Pharmaceuticals. Nov 17, 2008 510 Antares Pharma Enters Into a Feasibility Development Agreement with Dr. Reddy's Laboratories, Inc. for an Enhanced Dermatology Product Utilizing the ATD Gel Platform. Sep 3, 2008 793 Enrollment in Phase IIb Clinical Trial for I-vation(TM) TA (MK-0140) Suspended Pending Review of Study Design by Merck & Co., Inc. Aug 8, 2008 720 SurModics Announces Initiation by Merck & Co., Inc. of Phase IIb Clinical Trial for I-vation(TM) TA. Jun 25, 2008 672 Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic. Apr 21, 2008 818 SurModics Announces First Human Use of SynBiosys(TM) Biodegradable Polymer on CardioMind Drug-Eluting Stent. Mar 31, 2008 1157 GENEREX GETS APPROVAL FOR ORAL-LYN PHASE III TRIAL. Mar 1, 2008 453 Depomed Reports Positive Efficacy Data From a Phase 2 Trial of Gabapentin GR(TM) in the Treatment of Menopausal Hot Flashes. Medical condition overview Feb 12, 2008 1501 Unigene Initiates Phase I/II Clinical Study for Oral Calcitonin. Feb 11, 2008 587 Agreements. Dec 1, 2007 784 NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product. Jul 9, 2007 278 A.P. Pharma Clarifies Effective Date of Reverse Stock Split. May 24, 2007 347 SurModics Signs Agreement with St. Jude Medical. Apr 12, 2007 395 Preclinical Data on Cytogen's Technology to be Reported at the AACR Annual Meeting. Mar 29, 2007 949 SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals. Mar 9, 2007 970 Ipsen: Initiation of Phase III Clinical Trials with Decapeptyl(R)'s 4-Month Sustained Release Formulation. Dec 14, 2006 730 InSite Vision Announces Initiation of a Phase 1 Safety Trial on AzaSite Plus(TM). Nov 8, 2006 889 Inspire Begins Phase 2 Clinical Program of Epinastine for Seasonal Allergic Rhinitis. Oct 10, 2006 575 Acrux to Start USA Trial of Its Unique Testosterone Lotion For Men. Sep 18, 2006 737 Nektar Closes Its Bradford UK Site; Company Focusing on Development of Products Using its Drug Delivery Technology. Jul 26, 2006 691 A.P. Pharma Initiates APF530 Phase 3 Clinical Trial; IRB Approval Received. Apr 27, 2006 668 SurModics and Donaldson Company Announce Introduction of the First Jointly Developed Nanofiber Cell Culture Product; New Synthetic ECM Mimics 3-D Cell Growth in Body. Jan 30, 2006 1258 FeRx on FDA Fast Track for approval of new cancer treatment. (Biotech). Webb, Marion Brief Article Sep 9, 2002 216 Vivus Files NDA for the Treatment of Erectile Dysfunction. Mar 28, 1996 498 Two milestones in one month for Nanogen Inc. Fikes, Bradley Column Oct 16, 1995 1247